Alzheimer; News from the web:
An EU project has made important advances in our understanding of how catalytic molecules can treat Alzheimer’s – and other – chronic diseases.
Alzheimer’s disease is the most common form of dementia, with symptoms that include gradually worsening memory loss and confusion. At present there is no cure. Scientists are nonetheless confident that as we learn more about the natural processes of the body, quicker diagnoses and more effective therapies can be developed.
Indeed, the success of the EU-funded ORGANOZYMES project illustrates why medical researchers have cause for optimism. Through bringing in Spanish post-doc researcher Carlos Aydillo on a Marie Curie Intra-European Fellowship, Professor Morten Meldal, Head of the Center of Evolutionary Chemical Biology at the University of Copenhagen, has been able to make significant advances in the field of catalytic molecules.
Read all about it HERE